These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
893 related items for PubMed ID: 30468285
1. Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy. Shaker OG, Abdelaleem OO, Mahmoud RH, Abdelghaffar NK, Ahmed TI, Said OM, Zaki OM. IUBMB Life; 2019 Mar; 71(3):310-320. PubMed ID: 30468285 [Abstract] [Full Text] [Related]
2. Plasma miR-21 expression: an indicator for the severity of Type 2 diabetes with diabetic retinopathy. Jiang Q, Lyu XM, Yuan Y, Wang L. Biosci Rep; 2017 Apr 28; 37(2):. PubMed ID: 28108673 [Abstract] [Full Text] [Related]
3. Serum miR-122 levels correlate with diabetic retinopathy. Pastukh N, Meerson A, Kalish D, Jabaly H, Blum A. Clin Exp Med; 2019 May 28; 19(2):255-260. PubMed ID: 30673918 [Abstract] [Full Text] [Related]
4. Serum miRNA biomarkers serve as a fingerprint for proliferative diabetic retinopathy. Qing S, Yuan S, Yun C, Hui H, Mao P, Wen F, Ding Y, Liu Q. Cell Physiol Biochem; 2014 May 28; 34(5):1733-40. PubMed ID: 25427542 [Abstract] [Full Text] [Related]
5. High level of lncRNA NR2F1-AS1 predict the onset and progression of diabetic retinopathy in type 2 diabetes. Ji X, Sun J, Wang Z. Exp Eye Res; 2022 Jun 28; 219():109069. PubMed ID: 35398206 [Abstract] [Full Text] [Related]
6. Long noncoding RNA MALAT1 participates in the pathological angiogenesis of diabetic retinopathy in an oxygen-induced retinopathy mouse model by sponging miR-203a-3p. Yu L, Fu J, Yu N, Wu Y, Han N. Can J Physiol Pharmacol; 2020 Apr 28; 98(4):219-227. PubMed ID: 31689123 [Abstract] [Full Text] [Related]
7. RNA sequencing identified specific circulating miRNA biomarkers for early detection of diabetes retinopathy. Liang Z, Gao KP, Wang YX, Liu ZC, Tian L, Yang XZ, Ding JY, Wu WT, Yang WH, Li YL, Zhang ZB, Zhai RH. Am J Physiol Endocrinol Metab; 2018 Sep 01; 315(3):E374-E385. PubMed ID: 29812988 [Abstract] [Full Text] [Related]
8. Serum cortisol is a biomolecular biomarker for severity of diabetic retinopathy. Mohan A, Saxena S, Kaur A, Ali W, Akduman L. Mol Vis; 2021 Sep 01; 27():429-437. PubMed ID: 34267498 [Abstract] [Full Text] [Related]
9. Serum Extracellular Superoxide Dismutase Is Associated with Diabetic Retinopathy Stage in Chinese Patients with Type 2 Diabetes Mellitus. Zhao JS, Jin HX, Gao JL, Pu C, Zhang P, Huang JJ, Cheng L, Feng G. Dis Markers; 2018 Sep 01; 2018():8721379. PubMed ID: 29849828 [Abstract] [Full Text] [Related]
10. Dysregulation of miR-374a is involved in the progression of diabetic retinopathy and regulates the proliferation and migration of retinal microvascular endothelial cells. Wang Z, Zhang X, Wang Y, Xiao D. Clin Exp Optom; 2022 Apr 01; 105(3):287-292. PubMed ID: 33941051 [Abstract] [Full Text] [Related]
11. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy. Zou HL, Wang Y, Gang Q, Zhang Y, Sun Y. Graefes Arch Clin Exp Ophthalmol; 2017 Jun 01; 255(6):1159-1166. PubMed ID: 28382439 [Abstract] [Full Text] [Related]
12. Highly-Expressed MiR-221-3p Distinctly Increases the Incidence of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus. Zhao L, Pan Q. Transl Vis Sci Technol; 2023 Oct 03; 12(10):17. PubMed ID: 37856104 [Abstract] [Full Text] [Related]
13. Downregulation of plasma microRNA-29c-3p expression may be a new risk factor for diabetic retinopathy. Torus B, Korkmaz H, Ozturk KH, Şirin FB, Argun M, Şevik S, Tök L. Minerva Endocrinol (Torino); 2023 Mar 03; 48(1):42-50. PubMed ID: 33213115 [Abstract] [Full Text] [Related]
14. Screening for diabetic retinopathy in diabetic patients with a mydriasis-free, full-field flicker electroretinogram recording device. Zeng Y, Cao D, Yang D, Zhuang X, Yu H, Hu Y, Zhang Y, Yang C, He M, Zhang L. Doc Ophthalmol; 2020 Jun 03; 140(3):211-220. PubMed ID: 31720980 [Abstract] [Full Text] [Related]
15. MicroRNA-126: a promising novel biomarker in peripheral blood for diabetic retinopathy. Qin LL, An MX, Liu YL, Xu HC, Lu ZQ. Int J Ophthalmol; 2017 Jun 03; 10(4):530-534. PubMed ID: 28503423 [Abstract] [Full Text] [Related]
16. MicroRNAs (-146a, -21 and -34a) are diagnostic and prognostic biomarkers for diabetic retinopathy. Helal HG, Rashed MH, Abdullah OA, Salem TI, Daifalla A. Biomed J; 2021 Dec 03; 44(6 Suppl 2):S242-S251. PubMed ID: 35304162 [Abstract] [Full Text] [Related]
17. YAP1 is required for the angiogenesis in retinal microvascular endothelial cells via the inhibition of MALAT1-mediated miR-200b-3p in high glucose-induced diabetic retinopathy. Han N, Tian W, Yu N, Yu L. J Cell Physiol; 2020 Feb 03; 235(2):1309-1320. PubMed ID: 31313295 [Abstract] [Full Text] [Related]
18. Circulating miRNAs in diabetic retinopathy patients: Prognostic markers or pharmacological targets? Trotta MC, Gesualdo C, Platania CBM, De Robertis D, Giordano M, Simonelli F, D'Amico M, Drago F, Bucolo C, Rossi S. Biochem Pharmacol; 2021 Apr 03; 186():114473. PubMed ID: 33607073 [Abstract] [Full Text] [Related]
19. The changing features of serum adropin, copeptin, neprilysin and chitotriosidase which are associated with vascular endothelial function in type 2 diabetic retinopathy patients. Li B, Li N, Guo S, Zhang M, Li J, Zhai N, Wang H, Zhang Y. J Diabetes Complications; 2020 Nov 03; 34(11):107686. PubMed ID: 32768333 [Abstract] [Full Text] [Related]
20. Plasma Levels and Diagnostic Significance of miR-335-3p and EGFR in Diabetic Retinopathy. Xia Z, Yang X, Zheng Y, Yi G, Wu S. Clin Lab; 2022 Apr 01; 68(4):. PubMed ID: 35443588 [Abstract] [Full Text] [Related] Page: [Next] [New Search]